Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.10
-0.44 (-6.73%)
At close: Apr 3, 2025, 4:00 PM
6.32
+0.22 (3.60%)
After-hours: Apr 3, 2025, 7:01 PM EDT

Coya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-14.88-7.99-12.24-4.89-1.1
Depreciation & Amortization
0.030.030.030.02-
Other Amortization
--1--
Asset Writedown & Restructuring Costs
0.030.540.53--
Stock-Based Compensation
2.660.870.210.23-
Other Operating Activities
--2.5-0.4
Change in Accounts Payable
0.480.30.850.670.16
Change in Unearned Revenue
0.31.5---
Change in Other Net Operating Assets
1.1-6.44-0.090.07-0.04
Operating Cash Flow
-10.29-11.19-7.24-3.9-0.59
Capital Expenditures
----0.14-
Sale (Purchase) of Intangibles
-0.03-0.54-0.53--
Investing Cash Flow
-0.03-0.54-0.53-0.14-
Long-Term Debt Issued
--10.47--
Total Debt Issued
--10.47-0.23
Net Debt Issued (Repaid)
--10.47-0.23
Issuance of Common Stock
16.1638.4300-
Other Financing Activities
-0.13--1.11-0.340
Financing Cash Flow
16.0338.439.36-0.3413.67
Net Cash Flow
5.7126.691.59-4.3813.08
Free Cash Flow
-10.29-11.19-7.24-4.04-0.59
Free Cash Flow Margin
-289.50%-186.41%---
Free Cash Flow Per Share
-0.68-1.10-2.79-1.56-0.32
Levered Free Cash Flow
-6.73-10.33-3.43-2.45-
Unlevered Free Cash Flow
-6.73-10.33-4.43-2.45-
Change in Net Working Capital
-1.376.09-1.67-0.49-
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q